(Q59924786)

12 December 2020

Intravenous immune globulin for inducing remissions in systemic lupus erythematosus.

1 reference

12 December 2020

Cyclophosphamide and lupus nephritis: when, how, for how long?

1 reference

12 December 2020

Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden

1 reference

12 December 2020

Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.

1 reference

12 December 2020

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases

1 reference

12 December 2020

Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.

1 reference

12 December 2020

Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.

1 reference

12 December 2020

Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations

1 reference

12 December 2020

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

1 reference

12 December 2020

Matrix metalloproteinases in immunity.

1 reference

12 December 2020

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

1 reference

12 December 2020

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

1 reference

12 December 2020

Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus

1 reference

12 December 2020

The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

1 reference

12 December 2020

Dilemmas in neuropsychiatric lupus.

1 reference

12 December 2020

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

12 December 2020

Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus.

1 reference

12 December 2020

Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis Among Patients With Systemic Lupus Erythematosus

1 reference

12 December 2020

Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.

1 reference

12 December 2020

Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus

1 reference

12 December 2020

Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside

1 reference

12 December 2020

The antiphospholipid syndrome

1 reference

12 December 2020

The blood-brain barrier in systemic lupus erythematosus

1 reference

12 December 2020

Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates

1 reference

12 December 2020

Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer.

1 reference

12 December 2020

Immunotherapy of systemic lupus erythematosus

1 reference

12 December 2020

Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells

1 reference

12 December 2020

Prevalence of cognitive impairment in systemic lupus erythematosus.

1 reference

12 December 2020

Disorders that mimic central nervous system infections

1 reference

12 December 2020

Cognition and immunity; antibody impairs memory

1 reference

12 December 2020

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus

1 reference

12 December 2020

Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus

1 reference

12 December 2020

Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.

1 reference

12 December 2020

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

1 reference

12 December 2020

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

1 reference

12 December 2020

Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.

1 reference

12 December 2020

Acute psychosis in systemic lupus erythematosus

1 reference

12 December 2020

Anti-P antibodies and neuropsychiatric lupus erythematosus

1 reference

12 December 2020

Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.

1 reference

12 December 2020

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

1 reference

12 December 2020

Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.

1 reference

12 December 2020

Neuropsychiatric Systemic Lupus Erythematosus

1 reference

12 December 2020

Off-label use of rituximab in systemic lupus erythematosus: a systematic review

1 reference

12 December 2020

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

1 reference

12 December 2020

Neurologic manifestations of systemic lupus erythematosus in children and adults

1 reference

12 December 2020

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

1 reference

12 December 2020

Neuropsychiatric involvement in pediatric systemic lupus erythematosus

1 reference

12 December 2020

Anti-beta 2-glycoprotein I antibodies bind to central nervous system

1 reference

12 December 2020

The innate immune system in SLE: type I interferons and dendritic cells

1 reference

12 December 2020

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients

1 reference

12 December 2020

Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus

1 reference

12 December 2020

Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up.

1 reference

12 December 2020

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort

1 reference

12 December 2020

Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study

1 reference

12 December 2020

Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.

1 reference

12 December 2020

Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study

1 reference

12 December 2020

Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies.

1 reference

12 December 2020

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

12 December 2020

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

1 reference

12 December 2020

The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Antimalarial agents and lupus.

1 reference

12 December 2020

Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong

1 reference

12 December 2020

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

1 reference

12 December 2020

A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus

1 reference

12 December 2020

Mitoxantrone and cytotoxic drugs' mechanisms of action

1 reference

12 December 2020

Hippocampal atrophy in systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.

1 reference

12 December 2020

Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.

1 reference

12 December 2020

Cytokines and intrathecal IgG synthesis in multiple sclerosis patients during clinical remission

1 reference

12 December 2020

Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients

1 reference

12 December 2020

Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors

1 reference

12 December 2020

Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits

1 reference

12 December 2020

Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Brain injury and neurometabolic abnormalities in systemic lupus erythematosus.

1 reference

12 December 2020

Immunosuppressive drugs: the first 50 years and a glance forward

1 reference

12 December 2020

Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach

1 reference

12 December 2020

The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

1 reference

12 December 2020

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

1 reference

12 December 2020

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

1 reference

12 December 2020

Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study

1 reference

12 December 2020

Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system.

1 reference

12 December 2020

A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus

1 reference

12 December 2020

Cognition and mood in systemic lupus erythematosus. Evaluation and pathogenesis

1 reference

12 December 2020

Update on cyclophosphamide for systemic lupus erythematosus

1 reference

12 December 2020

Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus.

1 reference

12 December 2020

Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus

1 reference

12 December 2020

Interferon-alpha: a therapeutic target in systemic lupus erythematosus

1 reference

12 December 2020

The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients

1 reference

12 December 2020

Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus.

1 reference

12 December 2020

1 reference

12 December 2020

Antibodies to protein P in systemic lupus erythematosus

1 reference

12 December 2020

Neuroimaging in neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis

1 reference

12 December 2020

Autoantibodies in neuropsychiatric lupus.

1 reference

12 December 2020

Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus

1 reference

12 December 2020

Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET

1 reference

12 December 2020

Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement

1 reference

12 December 2020

Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Brain pathology in systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus

1 reference

12 December 2020

Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

1 reference

12 December 2020

Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study

1 reference

12 December 2020

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

1 reference

12 December 2020

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

1 reference

12 December 2020

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus

1 reference

12 December 2020

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

1 reference

12 December 2020

Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium

1 reference

12 December 2020

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

1 reference

12 December 2020

New therapies for systemic lupus erythematosus

1 reference

12 December 2020

Immunity and behavior: antibodies alter emotion

1 reference

12 December 2020

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

12 December 2020